Fluorescence polarization immunoassay and microparticle enzyme immunoassay

• Published in: Rinsho byori. The Japanese journal of clinical pathology Vol. 44; no. 11; p. 1072
• Main Authors: Suguri, M, Hirose, N, Myoga, A, Doss, R, Tatsumi, N
• Format: Journal Article
• Language: Japanese
• Published: Japan 01.11.1996
• Subjects: Fluorescence Polarization Immunoassay - instrumentation; Fluorescence Polarization Immunoassay - methods; Immunoenzyme Techniques - instrumentation
• ISSN: 0047-1860

We describe a new clinical laboratory instrument, the Abbott AxSYM, which provides random- and continuous-access testing for immunoassays, 20 onboard reagents, primary tube sampling, and a throughput of 80 to 120 tests per hour. The AxSYM incorporates three separate analytical technologies for processing immunoassays: microparticle enzyme immunoassay, fluorescence polarization immunoassay, and a novel technology known as ion-capture immunoassay. The system incorporates both common and technology-specific subsystems controlled by a real-time software scheduling processor. Tests can be processed in one- or two-step sandwich or competitive formats, with variable pipetting steps, incubation periods, optical read formats, and wash sequences. Menu capabilities include test for hepatitis, retrovirus, tumor markers, fertility markers, thyroid functions, and therapeutic drugs. The time to first result is 15 approximately 25 min for most routine assay and < or = 15 min for stat assays (i.e., creatine kinase MB isoenzyme, human chorionic gonadotropin beta subunit, and therapeutic drugs). AxSYM assay performance for 23 assays was comparable with that of the Abbott IMx and TDx analyzers; specimen correlation data had correlation from 0.99 to 1.10. Within-run imprecision (CV) was 1.5% to 11.4%, with most assays (19 of 23) demonstrating CVs < or = 8.0%.